When looking at a molecule that's transported around like RNA, how can you figure out where it's synthesized and where it ends up? See how researchers examined this very question in the 1950s. A ...

Dividend history information is presently unavailable for this company. This could indicate that the company has never provided a dividend or that a dividend is pending.

Get prepared with the key expectations. When MRNA reports third-quarter earnings, investors will likely focus on the sales performance of its recently approved RSV vaccine, mResvia. Get a deeper ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ...

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines ...

Upgrade your Yahoo Finance plan to get complete details for Moderna, Inc. Get advanced tools and insights to navigate the markets.